Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

NCT04464980 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
1516
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

NYU Langone Health

Collaborators